Cabrera-Perez Javier, Badovinac Vladimir P, Griffith Thomas S
1 Microbiology, Immunology, and Cancer Biology Graduate Program, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
2 Medical Scientist Training Program, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Exp Biol Med (Maywood). 2017 Jan;242(2):127-139. doi: 10.1177/1535370216669610. Epub 2016 Oct 4.
Sepsis is a poorly understood syndrome of systemic inflammation responsible for hundreds of thousands of deaths every year. The integrity of the gut epithelium and competence of adaptive immune responses are notoriously compromised during sepsis, and the prevalent assumption in the scientific and medical community is that intestinal commensals have a detrimental role in the systemic inflammation and susceptibility to nosocomial infections seen in critically ill, septic patients. However, breakthroughs in the last decade provide strong credence to the idea that our mucosal microbiome plays an essential role in adaptive immunity, where a human host and its prokaryotic colonists seem to exist in a carefully negotiated armistice with compromises and benefits that go both ways. In this review, we re-examine the notion that intestinal contents are the driving force of critical illness. An overview of the interaction between the microbiome and the immune system is provided, with a special focus on the impact of commensals in priming and the careful balance between normal intestinal flora and pathogenic organisms residing in the gut microbiome. Based on the data in hand, we hypothesize that sepsis induces imbalances in microbial populations residing in the gut, along with compromises in epithelial integrity. As a result, normal antigen sampling becomes impaired, and proliferative cues are intermixed with inhibitory signals. This situates the microbiome, the gut, and its complex immune network of cells and bacteria, at the center of aberrant immune responses during and after sepsis.
脓毒症是一种人们了解甚少的全身炎症综合征,每年导致数十万人死亡。在脓毒症期间,肠道上皮的完整性和适应性免疫反应的能力会受到严重损害,科学界和医学界普遍认为,肠道共生菌在重症脓毒症患者出现的全身炎症和医院感染易感性中起有害作用。然而,过去十年的突破有力地证明了我们的黏膜微生物群在适应性免疫中起着至关重要的作用,在这种情况下,人类宿主及其原核生物定居者似乎处于一种经过精心协商的休战状态,双方都有妥协和益处。在这篇综述中,我们重新审视肠道内容物是危重病驱动因素这一观点。本文概述了微生物群与免疫系统之间的相互作用,特别关注共生菌在启动过程中的影响以及肠道微生物群中正常肠道菌群与致病生物之间的微妙平衡。基于现有数据,我们推测脓毒症会导致肠道微生物种群失衡,同时上皮完整性受损。结果,正常的抗原采样受到损害,增殖信号与抑制信号相互交织。这使得微生物群、肠道及其复杂的细胞和细菌免疫网络处于脓毒症期间及之后异常免疫反应的中心。